|128.32||+3.29||+2.63%||Vol 278.52K||1Y Perf 50.26%|
|Sep 15th, 2021 16:00 DELAYED|
|- -%||- -|
|Target Price||156.83||Analyst Rating||Moderate Buy 2.00|
|Potential %||22.22||Finscreener Ranking||+ 39.29|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||+ 37.29|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★+ 48.99|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||+ 27.78|
|Price Range Ratio 52W %||75.91||Earnings Rating||Sell|
|Market Cap||3.74B||Earnings Date||27th Oct 2021|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||27th Oct 2021|
|Estimated EPS Next Report||0.77|
|EPS Growth Next 5 Years %||9.90|
|Avg. Weekly Volume||194.45K|
|Avg. Monthly Volume||186.72K|
|Avg. Quarterly Volume||214.51K|
Conmed Corp. - Ordinary Shares (NASDAQ: CNMD) stock closed at 128.32 per share at the end of the most recent trading day (a 2.63% change compared to the prior day closing price) with a volume of 280.45K shares and market capitalization of 3.74B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3400 people. Conmed Corp. - Ordinary Shares CEO is Curt R. Hartman.
The one-year performance of Conmed Corp. - Ordinary Shares stock is 50.26%, while year-to-date (YTD) performance is 14.57%. CNMD stock has a five-year performance of 229.03%. Its 52-week range is between 69.6 and 146.95, which gives CNMD stock a 52-week price range ratio of 75.91%
Conmed Corp. - Ordinary Shares currently has a PE ratio of 69.10, a price-to-book (PB) ratio of 4.82, a price-to-sale (PS) ratio of 3.66, a price to cashflow ratio of 34.30, a PEG ratio of 2.32, a ROA of 3.02%, a ROC of 6.42% and a ROE of 7.43%. The company’s profit margin is 5.70%, its EBITDA margin is 17.60%, and its revenue ttm is $978.50 Million , which makes it $33.55 revenue per share.
Of the last four earnings reports from Conmed Corp. - Ordinary Shares, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.77 for the next earnings report. Conmed Corp. - Ordinary Shares’s next earnings report date is 27th Oct 2021.
The consensus rating of Wall Street analysts for Conmed Corp. - Ordinary Shares is Moderate Buy (2), with a target price of $156.83, which is +22.22% compared to the current price. The earnings rating for Conmed Corp. - Ordinary Shares stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Conmed Corp. - Ordinary Shares has a dividend yield of 0.65% with a dividend per share of $0.80 and a payout ratio of 186.00%.
Conmed Corp. - Ordinary Shares has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.25, ATR14 : 3.36, CCI20 : -44.02, Chaikin Money Flow : 0.11, MACD : -1.27, Money Flow Index : 37.46, ROC : -4.56, RSI : 49.01, STOCH (14,3) : 51.42, STOCH RSI : 1.00, UO : 48.43, Williams %R : -48.58), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Conmed Corp. - Ordinary Shares in the last 12-months were: Barbara J Schwarzentraub (Option Excercise at a value of $0), Brian P. Concannon (Option Excercise at a value of $0), Charles M. Farkas (Option Excercise at a value of $0), Curt R. Hartman (Sold 0 shares of value $-10 844 640 ), Curt R. Hartman (Sold 90 377 shares of value $11 313 893 ), Daniel S. Jonas (Option Excercise at a value of $1 994 885), Daniel S. Jonas (Sold 36 600 shares of value $4 644 685 ), David M. Bronson (Option Excercise at a value of $0), Heather L. Cohen (Option Excercise at a value of $537 200), Heather L. Cohen (Sold 4 617 shares of value $655 220 ), Jerome J Lande (Option Excercise at a value of $0), John E. Kennedy (Option Excercise at a value of $2 676 626), John E. Kennedy (Sold 47 336 shares of value $4 875 514 ), John L. Workman (Option Excercise at a value of $0), Johonna Pelletier (Option Excercise at a value of $1 302 481), Johonna Pelletier (Sold 26 056 shares of value $2 943 928 ), LaVerne Council (Option Excercise at a value of $0), Mark E. Tryniski (Option Excercise at a value of $349 257), Mark E. Tryniski (Sold 8 265 shares of value $1 004 863 ), Martha Goldberg Aronson (Option Excercise at a value of $0), Stanley W. Peters (Sold 0 shares of value $-637 920 ), Stanley W. Peters (Sold 16 500 shares of value $1 636 250 ), Terence M. Berge (Option Excercise at a value of $2 583 877), Terence M. Berge (Sold 66 458 shares of value $7 065 760 ), Todd W. Garner (Option Excercise at a value of $0), Todd W. Garner (Sold 3 567 shares of value $474 760 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.